|
Mechanismβ2-adrenergic receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
左旋盐酸班布特罗片用于轻中度炎症性肠病两个剂量临床效果的Ⅱa 期探索性研究
[Translation] Phase IIa exploratory study on the clinical effects of two doses of Levorotatory Bambuterol Hydrochloride Tablets in mild to moderate inflammatory bowel disease
研究左旋盐酸班布特罗片用于轻中度炎症性肠病两个剂量的临床观察,评价两个剂量的量效关系,为正式二期提供依据。
[Translation] The purpose of this study is to conduct clinical observation on two doses of Levorotatory Bambuterol Hydrochloride Tablets for the treatment of mild to moderate inflammatory bowel disease, evaluate the dose-effect relationship of the two doses, and provide a basis for the formal Phase II trial.
100 Clinical Results associated with Hainan Zhongyu Pharmaceutical Co., Ltd
0 Patents (Medical) associated with Hainan Zhongyu Pharmaceutical Co., Ltd
100 Deals associated with Hainan Zhongyu Pharmaceutical Co., Ltd
100 Translational Medicine associated with Hainan Zhongyu Pharmaceutical Co., Ltd